Newsy's Latest Health News

Newsy's Latest Health News

Assessment

Interactive Video

Health Sciences, Biology

University

Hard

Created by

Quizizz Content

FREE Resource

Anthony Fauci warns that the COVID-19 situation may worsen, though he does not foresee a return to lockdowns due to vaccination progress. However, he emphasizes that more vaccinations are needed to end the outbreak. OBGYN groups recommend COVID-19 vaccination for pregnant individuals, citing safety evidence. They previously advised against withholding vaccines from pregnant people but now officially recommend vaccination. Recipients should be aware of rare blood clot risks associated with the Johnson & Johnson vaccine. The transcript concludes with a summary of health news.

Read more

5 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What does Dr. Fauci predict about the future of the COVID-19 pandemic?

The pandemic will end soon.

Vaccination rates are sufficient to end the outbreak.

Lockdowns will definitely return.

The situation may worsen, but lockdowns are unlikely.

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Why do medical groups recommend COVID-19 vaccination for pregnant individuals?

There is no evidence of safety during pregnancy.

Vaccines are proven safe during pregnancy.

Vaccines are mandatory for all pregnant individuals.

Pregnant individuals are immune to COVID-19.

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the stance of the American College of Obstetricians and Gynecologists on COVID-19 vaccination for pregnant people?

Vaccines are only for non-pregnant individuals.

Vaccines are unsafe for pregnant people.

Vaccines should be withheld from pregnant people.

Vaccines should be recommended based on safety evidence.

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What potential risk is associated with the Johnson & Johnson COVID-19 vaccine?

High fever

Rare blood clots

Severe allergic reactions

Permanent immunity

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Which COVID-19 vaccine is mentioned in relation to rare blood clot risks?

Pfizer

Moderna

Johnson & Johnson

AstraZeneca